Rituximab in maintaining remission in adults with podocytopathy-Reference-Cited by-同舟云学术

Rituximab in maintaining remission in adults with podocytopathy

Published:2020-06-14 Issue:8 Volume:25 Page:616-624
ISSN:1320-5358
Container-title:Nephrology
language:en
Short-container-title:Nephrology

Author:

Ramachandran Raja¹^ORCID,Bharati Joyita¹,Nada Ritambhra²,Minz Ranjana³,Kohli Harbir S.¹^ORCID

Affiliation:

1. Department of NephrologyPostgraduate Institute of Medical Education and Research Chandigarh India

2. Department of HistopathologyPostgraduate Institute of Medical Education and Research Chandigarh India

3. Department of ImmunopathologyPostgraduate Institute of Medical Education and Research Chandigarh India

Funder

Indian Council of Medical Research

Publisher

Wiley

Subject

Nephrology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nep.13717

Reference31 articles.

1. Management of Adult Minimal Change Disease

2. Treatment of Primary FSGS in Adults

3. PROSPECTIVE, CONTROLLED TRIAL OF CYCLOPHOSPHAMIDE THERAPY IN CHILDREN WITH THE NEPHROTIC SYNDROME *1Report of the International Study of Kidney Disease in Children

4. Mycophenolate Mofetil versus Cyclosporin A in Children with Frequently Relapsing Nephrotic Syndrome

5. Cyclosporin vs cyclophosphamide for patients with steroid‐dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial;Ponticelli C;Nephrol Dial Transplant,1993

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppression for adult steroid-dependent or frequently relapsing nephrotic syndrome: A systematic review and meta-analysis;PLOS ONE;2024-07-31

2. Rituximab in Steroid-Dependent Podocytopathies;Glomerular Diseases;2024-07-01

3. Japanese clinical practice patterns of rituximab treatment for minimal change disease in adults 2021: A web-based questionnaire survey of certified nephrologists;PLOS ONE;2024-03-29

4. Cytoskeleton Rearrangement in Podocytopathies: An Update;International Journal of Molecular Sciences;2024-01-04

5. The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult;Kidney International Reports;2022-08